299 related articles for article (PubMed ID: 9316395)
1. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.
Fowler E; Weiner HL
Biopolymers; 1997; 43(4):323-35. PubMed ID: 9316395
[TBL] [Abstract][Full Text] [Related]
2. Oral tolerance: therapeutic implications for autoimmune diseases.
Faria AM; Weiner HL
Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
[TBL] [Abstract][Full Text] [Related]
3. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
[TBL] [Abstract][Full Text] [Related]
4. Oral tolerance in the control of experimental models of autoimmune disease.
Staines NA; Harper N
Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
[TBL] [Abstract][Full Text] [Related]
5. Oral tolerance.
Komagata Y; Weiner HL
Rev Immunogenet; 2000; 2(1):61-73. PubMed ID: 11324694
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of experimental autoimmune diseases via oral tolerance.
Krause I; Blank M; Shoenfeld Y
Crit Rev Immunol; 2000; 20(1):1-16. PubMed ID: 10770268
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms and applications of oral tolerance].
Marth T; Kelsall BL; Strober W; Zeitz M
Z Gastroenterol; 1999 Feb; 37(2):165-85. PubMed ID: 10190250
[TBL] [Abstract][Full Text] [Related]
8. Peripheral deletion of antigen-reactive T cells in oral tolerance.
Chen Y; Inobe J; Marks R; Gonnella P; Kuchroo VK; Weiner HL
Nature; 1995 Jul; 376(6536):177-80. PubMed ID: 7603570
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
Laliotou B; Duncan L; Dick AD
J Autoimmun; 1999 May; 12(3):145-55. PubMed ID: 10222024
[TBL] [Abstract][Full Text] [Related]
10. [Induction of oral tolerance: a new therapeutic strategy for autoimmune diseases?].
Igaz P
Wien Med Wochenschr; 2000; 150(22):440-3. PubMed ID: 11191953
[TBL] [Abstract][Full Text] [Related]
11. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
12. Oral tolerance for the treatment of autoimmune diseases.
Weiner HL
Annu Rev Med; 1997; 48():341-51. PubMed ID: 9046967
[TBL] [Abstract][Full Text] [Related]
13. [Application of oral tolerance to the treatment of autoimmune diseases--active suppression and bystander suppression].
Matsui M
Nihon Rinsho; 1997 Jun; 55(6):1537-42. PubMed ID: 9200945
[TBL] [Abstract][Full Text] [Related]
14. [Gut mucosal immunity and oral tolerance].
Matsui M; Kuroda Y
Nihon Rinsho; 1994 Nov; 52(11):2873-9. PubMed ID: 7996683
[TBL] [Abstract][Full Text] [Related]
15. Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens.
Friedman A; al-Sabbagh A; Santos LM; Fishman-Lobell J; Polanski M; Das MP; Khoury SJ; Weiner HL
Chem Immunol; 1994; 58():259-90. PubMed ID: 8011155
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of immunological tolerance induction in adult mice by co-administration of pooled normal IgG and oral tolerogens: a potential therapeutic approach for autoimmune diseases.
Mengel J; Fávaro P; Meyer A; Motta V; de Alencar R; Postól E; Cardillo F
Med Hypotheses; 2005; 64(5):978-85. PubMed ID: 15780495
[TBL] [Abstract][Full Text] [Related]
17. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells.
Shi FD; Li H; Wang H; Bai X; van der Meide PH; Link H; Ljunggren HG
J Immunol; 1999 May; 162(10):5757-63. PubMed ID: 10229808
[TBL] [Abstract][Full Text] [Related]
19. History and mechanisms of oral tolerance.
Rezende RM; Weiner HL
Semin Immunol; 2017 Apr; 30():3-11. PubMed ID: 28774470
[TBL] [Abstract][Full Text] [Related]
20. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
Wolfraim LA
Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
